comprehensive -WSS

comprehensive

author：fashion 2025-09-29 01:45:37 - browse：291

U.S. legislation that would sever ties with Chinese drugmakers would jeopardize the drug supply for millions of American patients if it’s passed, the biotechnology industry’s main trade group has told Congress.

Congress is considering legislation, called the BIOSECURE Act, that would make it difficult for Chinese contract development and manufacturing organizations to do business with biotechnology companies that work with the U.S. federal government. Biotechs hire Chinese CDMOs, as they’re often called, for services that include product manufacturing, development, formulation, packaging, and distribution.

The BIOSECURE Act would stop the federal government from contracting with, or providing grants to, companies that do business with so-called Chinese “companies of concern.” The impact of the legislation would depend in large part on who is in the White House. The White House’s Office of Management and Budget would determine which companies are blacklisted, but a handful of specific companies would automatically go on that list, including the biotech giant WuXi AppTec.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： DeSantis talks Trump, trans issues and 'what wokeness is'

knowledge

WSS

Public funding for King Charles III and royals has been recalculated due to windfarm deal profits

Wife of Gilgo Beach murder suspect files for divorce, court filing shows

More people are opting for early dinners since the pandemic, says OpenTable CEO Debby Soo

Driven by the pandemic, applicants flood public health schools

'Stay indoors': Escaped wild animal on the loose in Berlin prompts urgent citywide search

More people are opting for early dinners since the pandemic, says OpenTable CEO Debby Soo

focus

comprehensive

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

entertainment

As demand for Covid shots wanes, Moderna seeks its next success

Boeing's 1st astronaut flight bumped into next year, more repairs needed

Walensky prepares to leave CDC — and Congress — behind

Elon Musk says he may need surgery before proposed 'cage match' with Mark Zuckerberg

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

'Stay indoors': Escaped wild animal on the loose in Berlin prompts urgent citywide search

Alkermes shareholders re

Driven by the pandemic, applicants flood public health schools

DIEP, the 'gold standard' of breast reconstruction, is under threat

Affordable Connectivity Program vital to health care, experts say

focus

More people are opting for early dinners since the pandemic, says OpenTable CEO Debby Soo

Study identifies new proteins linked to dementia risk 25 years later

Prince Harry and Meghan to work on film adaptation of 'Meet Me at the Lake' novel

A Q&A with Gavi’s Seth Berkley on vaccines, Covid, and more

'The Exorcist' director William Friedkin dead at 87

In medicine, common shorthands can shortchange care

hotspot

focus

knowledge

hotspot